UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 284

Sortiert nach

Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial

JAMA pediatrics, 2016-09, Vol.170 (9), p.840

2016

Volltextzugriff (PDF)

Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants

Pediatrics (Evanston), 2013-11, Vol.132 (5), p.811

2013

Volltextzugriff (PDF)

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

Infectious Diseases and Therapy, 2016-09, Vol.5 (3), p.271-298

2016

Volltextzugriff (PDF)

Chronic Diseases, Chromosomal Abnormalities, and Congenital Malformations as Risk Factors for Respiratory Syncytial Virus Hospitalization: A Population-Based Cohort Study

Clinical infectious diseases, 2012-03, Vol.54 (6), p.810-817

2012

Volltextzugriff (PDF)

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children

Infectious diseases and therapy, 2018-03, Vol.7 (1), p.87-120

2018

Volltextzugriff (PDF)

Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials

Nature communications, 2023-07, Vol.14 (1), p.4347-4347, Article 4347

2023

Volltextzugriff (PDF)

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood

Infectious diseases and therapy, 2017-06, Vol.6 (2), p.173-197

2017

Volltextzugriff (PDF)

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics

The Journal of infectious diseases, 2015-03, Vol.211 (suppl 1), p.S1-S20

2015

Volltextzugriff (PDF)

The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

The Lancet infectious diseases, 2018-10, Vol.18 (10), p.e295-e311

2018

Volltextzugriff (PDF)

Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation

PloS one, 2016-11, Vol.11 (11), p.e0166226-e0166226

2016

Volltextzugriff (PDF)

Upper airway gene expression shows a more robust adaptive immune response to SARS-CoV-2 in children

Nature communications, 2022-07, Vol.13 (1), p.3937-3937, Article 3937

2022

Volltextzugriff (PDF)

Invasive Bacterial Infections in Relation to Influenza Outbreaks, 2006-2010

Clinical infectious diseases, 2011-12, Vol.53 (12), p.1199-1207

2011

Volltextzugriff (PDF)

Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32–35 Weeks Gestation Not Receiving Immunoprophylaxis

The Pediatric infectious disease journal, 2014-06, Vol.33 (6), p.576-582

2014

Volltextzugriff (PDF)

Characteristics of SARS-CoV-2 Infections in Israeli Children During the Circulation of Different SARS-CoV-2 Variants

JAMA network open, 2021-09, Vol.4 (9), p.e2124343-e2124343

2021

Volltextzugriff (PDF)

Setting research priorities to reduce global mortality from childhood pneumonia by 2015

PLoS medicine, 2011-09, Vol.8 (9), p.e1001099-e1001099

2011

Volltextzugriff (PDF)

Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases

Infectious diseases and therapy, 2017-09, Vol.6 (3), p.383-411

2017

Volltextzugriff (PDF)

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals

The Journal of infectious diseases, 2008-11, Vol.198 (9), p.1317-1326

2008

Volltextzugriff (PDF)

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease

Infectious diseases and therapy, 2016-12, Vol.5 (4), p.417-452

2016

Volltextzugriff (PDF)

The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children

Journal of allergy and clinical immunology, 2010-08, Vol.126 (2), p.256-262

2010

Volltextzugriff (PDF)

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants

The New England journal of medicine, 2020-07, Vol.383 (5), p.415-425

2020

Volltextzugriff (PDF)

Using mathematical transmission modelling to investigate drivers of respiratory syncytial virus seasonality in children in the Philippines

PloS one, 2014-02, Vol.9 (2), p.e90094-e90094

2014

Volltextzugriff (PDF)

The Epidemiology of Respiratory Syncytial Virus Lower Respiratory Tract Infections in Children Less than 5 Years of Age in Indonesia

The Pediatric infectious disease journal, 2011-09, Vol.30 (9), p.778-784

2011

Volltextzugriff (PDF)

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

The New England journal of medicine, 2022-04, Vol.386 (17), p.1615-1626

2022

Volltextzugriff (PDF)

The Long-Term Healthcare Utilization and Economic Burden of RSV Infection in Children ≤5 Years in Japan: Propensity Score Matched Cohort Study

ClinicoEconomics and outcomes research, 2022-11, Vol.14, p.699-714

2022

Volltextzugriff (PDF)

Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children

Proceedings of the National Academy of Sciences - PNAS, 2014-03, Vol.111 (9), p.3520-3525

2014

Volltextzugriff (PDF)

1 – 25 von 284

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(256)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial

Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

Chronic Diseases, Chromosomal Abnormalities, and Congenital Malformations as Risk Factors for Respiratory Syncytial Virus Hospitalization: A Population-Based Cohort Study

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children

Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics

The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation

Upper airway gene expression shows a more robust adaptive immune response to SARS-CoV-2 in children

Invasive Bacterial Infections in Relation to Influenza Outbreaks, 2006-2010

Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32–35 Weeks Gestation Not Receiving Immunoprophylaxis

Characteristics of SARS-CoV-2 Infections in Israeli Children During the Circulation of Different SARS-CoV-2 Variants

Setting research priorities to reduce global mortality from childhood pneumonia by 2015

Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease

The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants

Using mathematical transmission modelling to investigate drivers of respiratory syncytial virus seasonality in children in the Philippines

The Epidemiology of Respiratory Syncytial Virus Lower Respiratory Tract Infections in Children Less than 5 Years of Age in Indonesia

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

The Long-Term Healthcare Utilization and Economic Burden of RSV Infection in Children ≤5 Years in Japan: Propensity Score Matched Cohort Study

Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children

Suchergebnisse filtern